NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Immunohistochemical detection of estrogen and progesterone receptor and HER2 expression in breast carcinomas: comparison of cell block and tissue block preparations.

Author(s): Williams SL, Birdsong GG, Cohen C, Siddiqui MT

Publication: Int J Clin Exp Pathol, 2009, Vol. 2, Page 476-80

PubMed ID: 19294006 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to compare estrogen (ER), progesterone (PR) and human epidermal growth factor 2 (HER-2) receptor status in breast cancer fine needle aspirate cell block (FNA CB) specimens fixed in ethanol with formalin-fixed tissue block (TB) specimens.

Conclusion of Paper

Positive immunohistochemical (IHC) staining results for ER and PR were 90.4% and 93.9% concordant, respectively between CB and TB specimens. However, agreement between FNA CB and TB specimens was only obtained 73.3% of the time with respect to positive HER-2 status. When positive and negative results were evaluated together, HER-2 staining discrepancy occurred 44.1% of the time. 60% of discrepant cases showed false positive HER-2 staining in FNA CB specimens.

Studies

  1. Study Purpose

    The purpose of this study was to compare ER, PR and HER-2 status of breast cancer specimens by IHC staining in FNA CB specimens fixed in ethanol with TB specimens fixed in formalin. Fixation of FNA CB specimens in ethanol was followed by formalin fixation.

    Summary of Findings:

    Positive IHC staining results for ER and PR were 90.4% and 93.9% concordant, respectively between CB and TB specimens. However, agreement between FNA CB and TB specimens was only obtained 73.3% of the time with respect to positive HER-2 status. When positive and negative results were evaluated together, HER-2 staining discrepancy occurred 44.1% of the time. 60% of discrepant cases showed false positive HER-2 staining in FNA CB specimens.

    Biospecimens
    Preservative Types
    • Ethanol
    • Formalin
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    Protein Immunohistochemistry
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Preservation Type of fixation/preservation Ethanol
    Formalin (buffered)
    Biospecimen Acquisition Method of tissue acquisition Fine needle aspiration
    Surgical resection

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...